Free Trial
NASDAQ:NDRAU

(NDRAU) (NDRAU) Stock Price, News & Analysis

→ These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad)
Free NDRAU Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$4.60
▼
$4.60
50-Day Range
N/A
52-Week Range
$4.01
▼
$5.50
Volume
N/A
Average Volume
3,548 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About (NDRAU)

ENDRA Life Sciences Inc. is engaged in commercialization of an enhanced ultrasound technology for the pre-clinical research market. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company is involved in developing TAEUS for incorporation into new ultrasound systems. The TAEUS platform has capabilities and potential clinical applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional ultrasound to visualize changes in tissue temperature, in real time; enabling ultrasound to view blood vessels from any angle, using only a saline solution contrasting agent, unlike Doppler ultrasound which requires precise viewing angles, and enabling ultrasound to image blood flow at the capillary level in a region, organ or tissue.

NDRAU Stock News Headlines

April 25, 2024 | msn.com
National study reports air pollution throughout New Mexico. How does your community rank?
See More Headlines
Receive NDRAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NDRAU) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:NDRAU
CUSIP
N/A
CIK
1681682
Web
www.endrainc.com
Phone
+1-734-3350468
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Francois Michelon (Age 51)
    Chairman of the Board, Chief Executive Officer
  • David R. Wells (Age 54)
    Chief Financial Officer
  • Michael Thornton (Age 48)
    Chief Technology Officer
  • Anthony DiGiandomenico (Age 50)
    Independent Director
  • Sanjiv Sam Gambhir (Age 54)
    Independent Director
  • Michael Harsh (Age 62)
    Independent Director
  • Alexander Tokman (Age 55)
    Independent Director

NDRAU Stock Analysis - Frequently Asked Questions

When did (NDRAU) IPO?

(NDRAU) (NDRAU) raised $8 million in an initial public offering on Tuesday, May 9th 2017. The company issued 1,700,000 shares at $5.00 per share. National Securities Corporation and Dougherty & Company acted as the underwriters for the IPO.

This page (NASDAQ:NDRAU) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
Fed launches fourth dollar overhaul
Stansberry Research
The only accurate crypto trading system I know …
Weiss Ratings